Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Penicillin-binding proteins (PBPs) are a diverse group of membrane-associated enzymes found in bacteria, characterized by their ability to bind penicillin and other β-lactam antibiotics. PBPs play essential roles in the biosynthesis of peptidoglycan, the main structural component of the bacterial cell wall. They catalyze transglycosylation (polymerization of glycan strands) and transpeptidation (cross-linking between glycan chains). Inhibition of PBPs leads to weakened cell walls and bacterial lysis. PBPs are validated targets for β-lactam antibiotics across many pathogenic bacteria. Mutations or acquisition of alternative low-affinity variants can confer resistance.
β-lactam antibiotics covalently bind to the active site serine residue within PBP’s transpeptidase domain, forming an acyl-enzyme complex that irreversibly inhibits enzymatic activity. This blocks peptidoglycan cross-linking and compromises cell wall integrity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Penicillin-binding protein (PBP).